Literature DB >> 9118456

Synthesis of a new potent anti-angiogenic agent, 17 alpha-acetoxy-9 alpha-fluoro-6 alpha-methylprogesterone (9 alpha-fluoromedroxyprogesterone acetate [FMPA]).

E Sugino1, S Fujimori, S Hibino, T Choshi, Y Ichihara, Y Sato, T Yamaji, H Tsuboi, N Murata, M Uchida, M Shimamura, T Oikawa.   

Abstract

A new anti-angiogenic agent, 17 alpha-acetoxy-9 alpha-fluoro-6 alpha-methylprogesterone (9 alpha-fluoromedoroxyprogesterone acetate [FMPA, 9] was synthetized in a 10-step sequence. FMPA (9) had about two orders of magnitude stronger anti-angiogenic activity than medroxyprogesterone acetate (MPA), as estimated in a bioassay involving chorioallantoic membranes of growing chick embryos.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9118456     DOI: 10.1248/cpb.45.421

Source DB:  PubMed          Journal:  Chem Pharm Bull (Tokyo)        ISSN: 0009-2363            Impact factor:   1.645


  1 in total

1.  Inhibition of angiogenesis by rhizoxin, a microbial metabolite containing two epoxide groups.

Authors:  C Onozawa; M Shimamura; S Iwasaki; T Oikawa
Journal:  Jpn J Cancer Res       Date:  1997-12
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.